The ThermoGenesis Blog is here to provide context for our products, solutions and customers. Follow us for more.

ThermoGenesis Holdings to Present at the H.C. Wainwright 24th Annual Global Investment Conference

RANCHO CORDOVA, Calif., September 7, 2022 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Chris Xu, Ph.D., Chief Executive Officer, will present a company overview at the H.C. Wainwright 24th Annual Global Investment Conference, taking place September … Continued

ThermoGenesis Holdings Announces Financial Results for the Second Quarter Ended June 30, 2022 and Provides Corporate Update

Driven by Sales of the AXP, Total Revenues for the Quarter Rose 38% Compared to Prior Year   Conference Call to be Held Today at 12:00 p.m. PT/3:00 p.m. ET   RANCHO CORDOVA, Calif., August 11, 2022 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the … Continued

How may we help?